Current News:
2008 Proxy Statement (Adobe Acrobat Reader download)
2007 Annual Report
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
First Quarter 2008 Earnings Release
Bioject to Report First Quarter 2008 Financial Results
Fourth Quarter 2007 and Year End Earnings Release (Replay) 03/18/07 at 7:00 a.m. PT
Bioject Reports December 31, 2007 Results and Initiates New Strategy
Chief Medical Officer to Present at International Needle-Free Conference on Advances in Bioject Technology
Bioject Note Holders Convert at Premium with Series F Convertible Preferred Stock
Bioject President and CEO to Present at OneMedPlace Emerging Healthcare Technologies Finance Forum
Bioject at the Forefront of Product Development with Use of Biojector® 2000
Bioject Secures Additional Funding to Reach Total of $1.2M Raised
Bioject Announces Convertible Debt Financing
Bioject President & CEO to present at The Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference, 11/07/07 at 11:30 a.m. EST
Third Quarter 2007 Earnings Release (Replay) 11/01/07 at 7:00 a.m. PT
New Supply Agreement with Merck Serono
New Chief Executive Officer Appointed
Nasdaq (SC): BJCT
ANNUAL REPORT